(Q33832530)

29 July 2017

1 reference

title

Role of protein tyrosine phosphatase-1B in diabetes and obesity (English)

1 reference

29 July 2017

Kennedy BP

1

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Biomedicine and Pharmacotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

53

1 reference

29 July 2017

issue

10

1 reference

29 July 2017

page(s)

466-470

1 reference

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Vanadium and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Vanadate stimulates in vivo glucose uptake in brain and arrests food intake and body weight gain in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Protein tyrosine phosphatases: counting the trees in the forest

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Protein tyrosine phosphatases: their role in insulin action and potential as drug targets.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

[Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

Genome scan for human obesity and linkage to markers in 20q13.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988105-6

7 January 2021

10.1016/S0753-3322(00)88105-6

Identifiers

DOI

1 reference

29 July 2017

1 reference